WIRE — Aurobindo Pharma reported a 25.2% year-on-year (YoY) rise in consolidated net profit to Rs 1,033 crore, while revenue increased 16.3% to Rs 9,150 crore.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.